← board
AAWH
distress 2/10 · well-funded / low risk$0.43+2%today-60% from 52w high
Revenue
$117M
Liquidity
$61M
Runway
—
Shares 1y
—
Price & events
-33.1% over 6M
CatalystRating changeDilutionFinancingdashed = today
+1.9%
1D
-2.9%
1W
-13.0%
1M
-23.3%
3M
-33.1%
6M
+8.6%
1Y
-54.5%
2Y
-95.9%
5Y
-95.5%
All
Overview
- Market Cap
- $86.87M
- Enterprise Value
- $318.26M
- Volume
- 54.10K
- 52 Week Range
- $0.35 – $1.08
- Total Shares
- 202.97M
- Float Shares
- 139.92M
- % Held by Insiders
- 20.29%
- % Held by Institutions
- 11.43%
- RVOL
- 1.34x
- Beta
- 1.76
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 2
- 2026-08-06Estimated 45%earningsEarningsEarnings releaseyahoo
- 2026-02-11partnershipSettlement agreement to resolve arbitration award for $17 million, fully satisfiedSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-16And The Sheriff Misses Out: Ascend Wellness Heading Toward Stock Exchange - Talking Joints Memo
- 2026-07-15Ascend Wellness Holdings Planning Stock Split Vote, Eyeing U.S. Stock Exchange Uplisting - Ganjapreneur
- 2026-07-13Ascend Wellness Announces Reverse Stock Split Vote in Support of Planned US Exchange Uplisting - Cannabis Business Times
- 2026-07-13Ascend Wellness schedules vote on reverse stock split - Investing.com
- 2026-07-13Ascend Wellness Holdings (AAWH.U) Proposes Reverse Stock Split to Facilitate U.S. Exchange Uplisting - Kalkine Media
- 2026-07-13Ascend Wellness schedules vote on reverse stock split By Investing.com - Investing.com Nigeria
- 2026-07-13Cannabis operator Ascend asks investors to back 1‑for‑10 to 1‑for‑50 reverse split - Stock Titan
- 2026-07-09Ascend Wellness (AAWH) seeks shareholder approval for wide-range reverse stock split - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.